Identification of women and girls with iron deficiency in the reproductive years

Int J Gynaecol Obstet. 2023 Aug:162 Suppl 2:58-67. doi: 10.1002/ijgo.14948.

Abstract

Iron deficiency (ID) is the most common micronutrient deficiency in the world. It is of concern for women and girls of reproductive age as, despite frequent normalization, excessive menstrual blood loss and the iron demands associated with pregnancy increase the risk of developing an ID. Iron deficiency reduces health-related quality of life with symptoms of fatigue, heart palpitations, difficulty concentrating, and poor mental health. When left untreated, ID can escalate to iron deficiency anemia (IDA), where there is an insufficiency of red blood cells, or hemoglobin within these cells, to meet the bodily demands for oxygen transport. Substantial guidance on screening for ID can be found in specific at-risk groups, including pregnant women and patients with renal, cardiac, and inflammatory bowel disease. However, it was unclear whether guidance is available for women of reproductive age. We performed a literature search to explore the current recommendations for screening women of reproductive age for ID. While four manuscripts supportive of screening were found, no official guidance appears to exist regarding screening for this group. In line with the World Health Organization's 10 Principles of Screening, we present a case for ID screening in women and girls of reproductive age.

Keywords: anemia; iron deficiency; menstruation; nutrition; reproductive health; screening; women.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Iron-Deficiency* / diagnosis
  • Anemia, Iron-Deficiency* / etiology
  • Female
  • Humans
  • Iron
  • Iron Deficiencies*
  • Pregnancy
  • Pregnant Women
  • Quality of Life

Substances

  • Iron